These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9673966)

  • 1. Effect of the 5-lipoxygenase inhibitor, fenleuton, on antigen-induced neutrophil accumulation and lung function changes in horses with chronic obstructive pulmonary disease.
    Marr KA; Lees P; Page CP; Cunningham FM
    J Vet Pharmacol Ther; 1998 Jun; 21(3):241-6. PubMed ID: 9673966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled leukotrienes cause bronchoconstriction and neutrophil accumulation in horses.
    Marr KA; Lees P; Page CP; Cunningham FM
    Res Vet Sci; 1998; 64(3):219-24. PubMed ID: 9690607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of fenleuton, a 5-lipoxygenase inhibitor, in ponies.
    Marr K; Marsh K; Hernandez L; Cunningham FM; Lees P
    Res Vet Sci; 1998; 64(2):111-7. PubMed ID: 9625466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the effect of a platelet activating factor (PAF) receptor antagonist on antigen challenge of horses with chronic obstructive pulmonary disease.
    Marr KA; Fairbairn SM; Page CP; Lees P; Cunningham FM
    J Vet Pharmacol Ther; 1996 Jun; 19(3):233-7. PubMed ID: 8803882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure.
    Fairbairn SM; Page CP; Lees P; Cunningham FM
    Clin Exp Allergy; 1993 Oct; 23(10):821-8. PubMed ID: 10780888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary disease.
    Fairbairn SM; Marr KA; Lees P; Cunningham FM; Page CP
    Res Vet Sci; 1996 Sep; 61(2):107-13. PubMed ID: 8880978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of equine neutrophil function by phosphodiesterase inhibitors.
    Rickards KJ; Page CP; Lees P; Cunningham FM
    J Vet Pharmacol Ther; 2001 Aug; 24(4):275-81. PubMed ID: 11555183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunixin meglumine blocks frusemide-induced bronchodilation in horses with chronic obstructive pulmonary disease.
    Rubie S; Robinson NE; Stoll M; Broadstone RV; Derksen FJ
    Equine Vet J; 1993 Mar; 25(2):138-42. PubMed ID: 8467773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease (COPD): effects of bronchodilator drugs on normal and affected horses.
    Murphy JR; McPherson EA; Dixon PM
    Equine Vet J; 1980 Jan; 12(1):10-4. PubMed ID: 6767605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of the maximal change in pleural pressure during tidal breathing in COPD-affected horses.
    Robinson NE; Derksen FJ; Olszewski M; Berney C; Boehler D; Matson C; Hakala J
    Vet J; 1999 Mar; 157(2):160-5. PubMed ID: 10204411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD).
    Franchini M; Gilli U; Akens MK; Fellenberg RV; Bracher V
    Vet Immunol Immunopathol; 1998 Nov; 66(1):53-65. PubMed ID: 9847020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antigen challenge on the activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease.
    Marr KA; Foster AP; Lees P; Cunningham FM; Page CP
    Res Vet Sci; 1997; 62(3):253-60. PubMed ID: 9300544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway response of horses with COPD to dry powder inhalation of ipratropium bromide.
    Duvivier DH; Votion D; Vandenput S; Art T; Lekeux P
    Vet J; 1997 Sep; 154(2):149-53. PubMed ID: 9308401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of horses affected with chronic obstructive pulmonary disease to inhalation challenges with mould antigens.
    McGorum BC; Dixon PM; Halliwell RE
    Equine Vet J; 1993 Jul; 25(4):261-7. PubMed ID: 8354208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen challenge increases adherence of circulating neutrophils in horses with chronic obstructive pulmonary disease.
    Marr KA; Lees P; Cunningham FM
    Equine Vet J; 2002 Jan; 34(1):65-70. PubMed ID: 11817553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD.
    Duvivier DH; Bayly WM; Votion D; Vandenput S; Art T; Farnir F; Lekeux P
    Equine Vet J; 1999 Jan; 31(1):20-4. PubMed ID: 9952325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of anaphylaxis but not activated neutrophils augment cholinergic responses of equine small airways.
    Olszewski MA; Robinson NE; Zhu FX; Zhang XY; Tithof PK
    Am J Physiol; 1999 Mar; 276(3):L522-9. PubMed ID: 10070118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease in the horse. 2: Therapy.
    Thomson JR; McPherson EA
    Equine Vet J; 1983 Jul; 15(3):207-10. PubMed ID: 6411459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi.
    Matera MG; Calzetta L; Rogliani P; Bardaro F; Page CP; Cazzola M
    Pulm Pharmacol Ther; 2011 Apr; 24(2):221-6. PubMed ID: 21195788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonate metabolites in bronchoalveolar lavage fluid from horses with and without COPD.
    Watson ED; Sweeney CR; Steensma KA
    Equine Vet J; 1992 Sep; 24(5):379-81. PubMed ID: 1396512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.